Fact Sheet
Reduce Regulatory Risk in Global Trials with Qualified eSignature (QES)
Ensure eConsent compliance across regions, study types and regulatory requirementsEnsure eConsent compliance across regions, study types and regulatory requirements
Jul 17, 2026
Download
Navigating electronic signature requirements across regions, study types, and risk profiles can be complex for clinical trial sponsors. This fact sheet explores when Qualified Electronic Signatures (QES) may be required, key eSignature considerations under EU eIDAS regulations, and best practices for maintaining compliant electronic consent processes in global and decentralized clinical trials.

Related solutions